GSA Capital Partners’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-204,243
Closed -$547K 2042
2022
Q4
$547K Buy
204,243
+50,068
+32% +$132K 0.07% 549
2022
Q3
$441K Buy
154,175
+122,711
+390% +$522K 0.06% 667
2022
Q2
$156K Buy
31,464
+7,425
+31% +$38.9K 0.02% 1130
2022
Q1
$171K Buy
+24,039
New +$199K 0.02% 1210
2021
Q4
Sell
-71,817
Closed -$1.41M 1909
2021
Q3
$1.41M Buy
+71,817
New +$2.73M 0.14% 150

Other funds holding CELL

GSA Capital Partners's CELL Position: Q1 2023 in Review

GSA Capital Partners sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 204,243 shares — an estimated $547K sold.

GSA Capital Partners first reported a position in CELL in Q3 2021 and held it in 5 quarters. The position peaked at $1.41M in Q3 2021. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • GSA Capital Partners reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 204,243 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $547K.
  • GSA Capital Partners first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • GSA Capital Partners's PhenomeX Inc. Common Stock position peaked at $1.41M in Q3 2021.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.